Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings

The Journal of Infectious Diseases
Lisa R HirschhornWilliam Rodriguez

Abstract

The expansion of human immunodeficiency virus (HIV) care and treatment in Africa and other resource-limited settings has begun to mitigate the impact of the acquired immunodeficiency syndrome pandemic. As this expansion has occurred, critical research has been conducted that has helped to define best practices and establish guidelines in HIV care. However, despite this research, a tremendous gap exists between the actual delivery of care and those strategies with proven efficacy in the clinical research setting: the program-implementation gap. The field of implementation research has the potential to fill this knowledge gap and to address the barriers to the effective replication of evidence-based interventions in local settings. This article reviews the current understanding of the field of implementation research and discusses its association with other areas of health services research, clinical research, and quality management work. Opportunities for conducting implementation research are proposed, and future steps to develop the field are outlined.

References

May 11, 1996·BMJ : British Medical Journal·N Black
Apr 1, 1996·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·I H Reerink, R Sauerborn
Apr 9, 1999·International Journal of Epidemiology·J P HabichtJ P Vaughan
Feb 13, 2001·BMJ : British Medical Journal·S MacintyreR Smith
Jul 13, 2002·BMJ : British Medical Journal·Donald M Berwick
Dec 12, 2003·The New England Journal of Medicine·Gregory K RobbinsUNKNOWN AIDS Clinical Trials Group 384 Team
Mar 5, 2004·American Journal of Public Health·Cesar G VictoraJennifer Bryce
Jul 13, 2004·The New England Journal of Medicine·Marc LallemantUNKNOWN Perinatal HIV Prevention Trial (Thailand) Investigators
Nov 17, 2005·Annals of Internal Medicine·Ira B WilsonPaul D Cleary
May 3, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Freddy PerezFrançois Dabis
May 30, 2006·PLoS Medicine·David Sanders, Andy Haines
Jun 13, 2006·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Lisa R HirschhornPaul D Cleary
Jun 24, 2006·PLoS Medicine·Elizabeth A McCarthyWilliam R Rodriguez
Aug 1, 2006·Bulletin of the World Health Organization·Kevin De Cock, Ian Grubb
Sep 5, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sam AmirfarSalim S Abdool Karim
Sep 15, 2006·The New England Journal of Medicine·Sue J GoldieKenneth A Freedberg
Jan 12, 2007·The New England Journal of Medicine·Shahin LockmanMax Essex
Jan 30, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ray Y ChenMichael S Saag
Mar 23, 2007·Expert Opinion on Pharmacotherapy·Andrew HillEsteban Ribera
Apr 7, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Xuanhong ChengWilliam R Rodriguez
Jan 10, 2008·AIDS·Zunyou WuUNKNOWN National Institute of Mental Health (NIMH) Collaborative HIV/STD Prevention Trial Group

❮ Previous
Next ❯

Citations

Jun 1, 2010·International Health·Leslie A CurryElizabeth H Bradley
Apr 22, 2008·The Journal of Infectious Diseases·Lisa R Hirschhorn, Richard Skolnik
Nov 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Bruce R Schackman
Dec 31, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sabina S Alistar, Margaret L Brandeau
Dec 4, 2012·Journal of the International AIDS Society·Kimon DivarisGodfrey Woelk
Jan 25, 2012·Bulletin of the World Health Organization·Bridget Pratt, Bebe Loff
Aug 14, 2009·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Jason S HaukoosUNKNOWN Denver ED HIV Opt-Out Study Group
Dec 22, 2012·The Lancet Infectious Diseases·Larry W ChangSteven J Reynolds
Nov 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neo M TapelaLawrence N Shulman
Jan 18, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nancy S PadianEric P Goosby
Apr 18, 2009·Current Opinion in HIV and AIDS·Debrework ZewdieJacqueline Bataringaya
Jan 27, 2020·Lifetime Data Analysis·Giorgos BakoyannisConstantin T Yiannoutsos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.